Dark

JNJ
Johnson & Johnson
stock NYSE

Market Open

May 9, 2025 2:11:06 PM EDT

154.85USD-0.520%(-0.81)2,775,231

154.84Bid 154.88Ask 0.04Spread

Pre-market

May 9, 2025 9:28:59 AM EDT

155.70USD+0.026%(+0.04)2,822

After-hours

May 8, 2025 4:50:30 PM EDT

155.66USD+0.071%(+0.11)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 31, 2022

02:32PM EST Johnson & Johnson Whale Trades Spotted Benzinga

05:40AM EST Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target Benzinga

Jan 27, 2022

05:29PM EST Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference PR Newswire

07:58AM EST The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study Benzinga

Jan 26, 2022

11:31AM EST Fauci Boosted Johnson & Johnson Shots Give Comparable Protection To Moderna Benzinga

07:36AM EST 10 Biggest Price Target Changes For Wednesday Benzinga

07:29AM EST Raymond James Maintains Outperform on Johnson & Johnson, Raises Price Target to $185 Benzinga

Jan 25, 2022

02:32PM EST Mid-Afternoon Market Update: Dow Turns Higher; General Electric Shares Slide Benzinga

12:42PM EST This Is What Whales Are Betting On Johnson & Johnson Benzinga

12:14PM EST Mid-Day Market Update: Nasdaq Tumbles 300 Points; Sierra Oncology Shares Jump Benzinga

10:05AM EST Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Sales Miss Views Benzinga

07:46AM EST The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data Benzinga

07:12AM EST Johnson & Johnson: Q4 Earnings Insights Benzinga

06:59AM EST Johnson & Johnson (JNJ) said the company is well positioned for success in 2022 and beyond. For 2022, the company targets adjusted operational sales growth of 7.7% and adjusted operational EPS growth of 9.2%. RTTNews

06:30AM EST Johnson & Johnson (JNJ) reported earnings for its fourth quarter that increased from the same period last year and beat the Street estimates. RTTNews

06:28AM EST Johnson & Johnson Sees FY22 Adj. EPS $10.40-$10.60 vs $10.37 Est., Operational Sales $100.3B-$100.4B Benzinga

06:27AM EST Johnson & Johnson Expects 2022 Adjusted Operational EPS Growth Of 9.2%, Adjusted Operational Sales Growth Of 7.7% Benzinga

06:27AM EST Johnson & Johnson Q4 EPS $1.77; Adj EPS $2.13 RTTNews

06:26AM EST Johnson & Johnson Reports Q4 and Full-Year 2021 Results PR Newswire

06:26AM EST Johnson & Johnson Q4 Adj. EPS $2.13 Beats $2.12 Estimate, Sales $24.80B Miss $25.29B Estimate Benzinga

05:34AM EST A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting Benzinga

04:03AM EST Earnings Scheduled For January 25, 2022 Benzinga

Jan 24, 2022

04:41PM EST Johnson & Johnson Says Newly Published Network Meta-Analysis Found Tremfya Ranked Highest For Overall Level Of Skin Clearance Benzinga

03:40PM EST L3Harris Appoints Michelle Turner As Finance Chief Benzinga

12:44PM EST Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows Benzinga

10:05AM EST Johnson & Johnson's Earnings: A Preview Benzinga

07:58AM EST Morgan Stanley Maintains Equal-Weight on Johnson & Johnson, Lowers Price Target to $175 Benzinga

07:58AM EST From Oxford: Third Booster Of Either AstraZeneca, Pfizer, Janssen Or Sinovac COVID Shot Induce Higher Antibodies In Those Who Previously Got Two Sinovac Doses Benzinga

Jan 23, 2022

11:03AM EST The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More Benzinga

Jan 20, 2022

12:57PM EST A Look Into Johnson & Johnson's Price Over Earnings Benzinga

Jan 18, 2022

11:39AM EST WHO Chief Scientist Soumya Swaminathan Says There Is No Evidence Right Now That Healthy Children, Healthy Adolescents Need COVID-19 Boosters Benzinga

10:13AM EST EU Regulator Says No Evidence Seen Yet To Recommend 4th Dose Of COVID-19 Vaccines Benzinga

Jan 14, 2022

04:13PM EST Johnson & Johnson Issues Statement On New Mexico Opioid Settlement Agreement; Says Co Is Removed From Pending Litigation By State Of New Mexico, Subdivisions; Says $44M Settlement Consistent With Terms Of Previously Announced Nationwide Opioid Settlement Benzinga

11:24AM EST What To Expect When Johnson & Johnson Unveils Q4 Performance This Month Benzinga

08:46AM EST Johnson and Johnson' COVID-19 Booster Is 85% Effective Against Omicron Hospitalization, South African Study Shows Benzinga

07:16AM EST J&J Shares Quiet As Pandemic Response Accountability Committee Recommends Change To Product Info For J&J's Janssen's COVID Vaccine To Include Warning To Raise Awareness Of Very Rare Cases Of 'TM'; BZ NOTE: Newsdesk Not Sure What 'TM' Refers To Benzinga

Jan 13, 2022

02:30PM EST Supreme Court Blocks President Biden's Workplace Vaccine-Or-Test Mandate For Larger Employers; Grants Administration Request To Enforce Vaccine Mandate For Healthcare Workers Nationwide Benzinga

11:51AM EST J&J Shares Unaffected Amid Headline FDA Has Approved Co.'s New Mentor, Memorygel Boost Breast Implant Benzinga

Jan 11, 2022

02:13PM EST FDA Amends Johnson & Johnson's Emergency Use Authorization To Include Immune Thrombocytopenia Warnings Benzinga

10:25AM EST EU Drug Regulator Says Should Be Careful In Not Overloading Immune System With Repeated COVID-19 Immunization Benzinga

Jan 6, 2022

10:07PM EST A real-world study showed that a single shot of the Johnson & Johnson COVID-19 vaccine resulted in long-lasting protection for up to six months against COVID-19 breakthrough infections, hospitalizations, and intensive care unit (ICU) admissions, the company said in a statement. RTTNews

04:14PM EST Johnson & Johnson Announces Results From Largest Study To Date On Durability Of COVID-19 Vaccines In US RTTNews

04:12PM EST Johnson & Johnson Highlights Results From Study Showing Single Shot Of Co.'s COVID-19 Vaccine Resulted In Long-Lasting Protection Up To Six Months Benzinga

04:11PM EST Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States PR Newswire

01:54PM EST White House Says Vaccine Mandates Related To Schools Are Always Up To School Districts Benzinga

Jan 5, 2022

04:05PM EST Tactile Medical Announces New Appointments to Board of Directors GlobeNewswire Inc

Jan 4, 2022

06:27PM EST 9 Of The Largest M&A Deals From 2021: WarnerMedia+Discovery, Kansas City Southern+Canadian National And More Benzinga

01:31PM EST U.S. Administration Expects 4M COVID Anti-Viral Treatments Available By End Of Jan., 10M By June Benzinga

09:42AM EST UPDATE: CDC Says Booster Interval Recommendation For People Who Receive J&J Vaccine (2 Months) Or Moderna Vaccine (6 Months) Has Not Changed Benzinga

09:37AM EST CDC Recommends Pfizer Booster At 5 Months, Additional Primary Dose For Certain Immunocompromised Children Benzinga

08:06AM EST Johnson & Johnson (JNJ) Declares $ 1.06 Dividend for Q1 22, Record Date 2/22/2022 RTTNews

08:03AM EST Johnson & Johnson Declares Q1 Cash Dividend Of $1.06, Payable March 8, Record Feb. 22 RTTNews

08:01AM EST Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022 PR Newswire

07:22AM EST Genocea Biosciences Enters R&D Collaboration And Option Agreement With Janssen Benzinga

Jan 3, 2022

10:24AM EST Starbucks To Require U.S. Vaccination Disclosure By Jan. 10; Unvaccinated Workers Will Need Weekly COVID Tests Benzinga

06:22AM EST Teva Suffers Loss In New York's Opioid Trial Benzinga

Dec 30, 2021

11:47AM EST 'F.D.A. Is Said to Be Near Allowing Boosters for 12- to 15-Year-Olds' -New York Times Report Benzinga

09:49AM EST Price To Earnings Ratio Insights For Johnson & Johnson Benzinga

07:11AM EST Johnson & Johnson's (JNJ) COVID-19 booster shot has provided strong protection against the Omicron variant, and reduced the risk of hospitalization, as per preliminary results from the South African Phase 3b Sisonke study. RTTNews

06:34AM EST Johnson & Johnson COVID-19 Vaccine Shows 85% Effectiveness Against Hospitalization In South African Phase 3b Study RTTNews

06:31AM EST Johnson & Johnson COVID-19 Vaccine Demonstrates 85% Effectiveness Against Hospitalization In South Africa When Omicron Was Dominant Benzinga

06:30AM EST Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness PR Newswire

Dec 29, 2021

12:11PM EST Johnson & Johnson Whale Trades Spotted Benzinga

08:01AM EST FDA Is Looking At Boosters For Kids 12-15 Benzinga

Dec 27, 2021

04:06PM EST Goldman Sachs Spokesperson Says Starting In Feb, Anyone Eligible To Get Booster Shot Will Be Required To Have One To Enter Goldman Offices In US Benzinga

09:13AM EST Swiss Medic Says Approves Booster Dose With The COVID-19 Vaccine From Janssen-Cilag Ag; Says Agency Has Approved The Authorization Application, Which Means That Persons Aged 18 Years And Older Can Now Receive A Booster Dose After A First Vaccination Benzinga

Dec 23, 2021

12:13PM EST UK Says COVID Omicron Variant Hospital Risk 50-70% Lower Than Compared To Delta Variant Benzinga

11:18AM EST 'New Jersey reports more than 15,000 new COVID cases, more than double the pre-omicron record and up almost 60% in just one day' -Tweet From NBC New York Benzinga

09:07AM EST Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table Benzinga

05:56AM EST U.S. Equity Futures Higher Ahead of Christmas Weekend; Positive News on Effectiveness of Vaccines Against Omicron Variant Benzinga

Dec 22, 2021

03:54PM EST 'New York reports 28,924 new coronavirus cases, the biggest one-day increase on record, of which 17,221 are in New York City' -Tweet From BNO Newsroom Benzinga

03:35PM EST White House Advisor Dr. Fauci Says Attending Large Gatherings Of 40+ People Is Not Considered Safe For Vaccinated, Boosted People Benzinga

11:28AM EST J&J's Janssen FDA AccessData.gov Listing Shows Submission Status 'Approval' For Co.'s Rybrevant Benzinga

11:22AM EST Study Out Of Scotland Shows Risk Of Hospital Admission For Patients With COVID Omicron Variant Reduced By 2/3 vs Delta Variant Benzinga

05:38AM EST U.S. Equity Futures Lower, European Markets Mixed; Governments Across the World Tighten Restrictions Due to Omicron Surge; Tech Companies Cancel Out of CES Vegas Event Benzinga

Dec 21, 2021

03:36PM EST 'Majority in the Immunization Committee in Israel votes for the provision of a fourth vaccine dose to at-risk groups - vaccine-suppressed, adults over the age of 60 and health care workers.' -Israel Reporter Tweet Benzinga

03:23PM EST 'Chicago to require proof of vaccination at restaurant, bars' -CNBC Benzinga

10:24AM EST NYC Mayor's Office Tweets '@NYCMayor just announced a new $100 incentive for New Yorkers if they get their booster shot at City-run sites before December 31.' Benzinga

09:51AM EST DYAI: Jumpin' Janssen Jamboree Benzinga

08:12AM EST The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail Benzinga

Dec 20, 2021

02:43PM EST Biden Admin. Has Pushed Bank Enforcement Of New Vaccine Rules Benzinga

11:34AM EST WHO's Chief Scientist Says 'Very Dangerous' To Jump To Conclusion That All Vaccines, Except mRNA Shots, Are Not Working Against Omicron Variant Benzinga

08:41AM EST EMA Head Says COVID Vaccines Clearly Less Effective Against Omicron; Says Data On Omicron Not At All Definitive But It's Clear That There Is A Drop In Vaccine Effectiveness Benzinga

05:28AM EST U.S. Equity Futures, European Markets Fall Sharply Over Rising Omicron Concerns; Two U.S. Senators Test Positive for Covid-19; Moderna Said Booster Effective vs Omicron; Senator Manchin Says he Will Not Support Biden Spending Bill Benzinga

Dec 19, 2021

07:20PM EST New Jersey Democratic Senator Cory Booker Says He Has Tested Positive for Covid-19 Benzinga

05:16PM EST Massachusetts Senator Warren Tests Positive for Covid-19 Benzinga

Dec 17, 2021

04:16PM EST The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More Benzinga

10:18AM EST Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 Benzinga

08:10AM EST White House Says No New Recommendations Yet On COVID-19 Amid Omicron But Continuing To Assess Any Possible New Steps Benzinga

07:43AM EST Goldman Sachs Initiates Coverage On Johnson & Johnson with Neutral Rating, Announces Price Target of $161 Benzinga

07:15AM EST Dyadic Reports Research, License, Collab Deal With J&J's Janssen For Manufacture Of Therapeutic Protein Candidates Using Its C1 Platform Benzinga

07:13AM EST 'Sinopharm, J&J, Sputnik Vaccines Are Weaker Against Omicron In New Study' -Recent Bloomberg Article Benzinga

Dec 16, 2021

09:33PM EST U.S. Centers for Disease Control and Prevention or CDC recommends that people take the mRNA COVID-19 vaccines made by Pfizer and Moderna instead of Johnson & Johnson's single-shot COVID-19 vaccine due to a rare blood clotting disorder. RTTNews

05:29PM EST J&J Says Remains Confident In Overall Positive Benefit-Risk Profile Of Its COVID-19 Vaccine Benzinga

03:45PM EST 'CDC advisory committee vote on whether to say mRNA #covid19 vaccines are preferred over J&J vaccine for everyone 18+: Yes: 15 No: 0' -Tweet From CNBC's Meg Tirrell Benzinga

01:57PM EST World Trade Organization Chief Says Parties Getting Close To Solution In Dispute Over COVID-19 Vaccine Rights Benzinga

01:45PM EST 'De Blasio says NYC looking at question of requiring boosters for teachers and other city employees "on the front burner," will say more soon' -NBC New York Report Benzinga

01:03PM EST CDC Panel Work Group Says Blood Clot Reporting Rate Following Johnson & Johnson COVID-19 Vaccine Is Higher Than Previous Estimates Benzinga

12:16PM EST CDC Says There Have Been 8 Reports To Vaccine Adverse Event Reporting System That Meet Definition Of Myocarditis Among Children Aged 5-11 Who Received COVID-19 Vaccine Benzinga

12:15PM EST U.S. CDC Says No Confirmed Reports Of Myocarditis In Vaccine Safety Datalink Monitoring System Among Children Aged 5-11 Who Received COVID-19 Vaccine Benzinga

Dec 15, 2021

11:34AM EST 'Our booster vaccine regimens work against omicron - at this time there's no need for a variant-specific booster," Dr Fauci says at @WHCOVIDResponse briefing' -Tweet From CNBC's Meg Tirrell Benzinga

11:27AM EST CDC's Walensky Says Will Release Vaccine, Booster Data On Thursday Benzinga

11:27AM EST CDC's Walensky Says Early Data Suggests Omicron Has A Doubling Time Of About 2 Days According To Early Research Benzinga

11:15AM EST European Medicines Committee Backs Johnson & Johnson's COVID-19 Booster Dose Benzinga

11:13AM EST Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back Benzinga

08:46AM EST Johnson & Johnson Receives Positive CHMP Opinion For RTTNews

08:34AM EST Johnson & Johnson Announces Positive CHMP Opinion For Booster Shot Of Its COVID-19 Vaccine Benzinga

08:34AM EST Johnson & Johnson Announces Positive CHMP Opinion For Booster Shot Of COVID-19 Vaccine RTTNews

08:32AM EST Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its PR Newswire

06:53AM EST European Medicines Agency or EMA, on Wednesday, recommended that a booster dose of Covid-19 Vaccine Janssen, developed by Janssen Pharmaceuticals, an arm of Johnson & Johnson (JNJ), may be considered at least 60 days after the first dose in individuals aged 18 years and above. RTTNews

06:09AM EST EMA Recommends J&J COVID-19 Booster Dose In Adults RTTNews

05:33AM EST EMA's Human Medicines Committee Concluded That Booster Dose of Covid-19 Vaccine Janssen May Be Considered at Least Two Months After the First Dose in People Aged 18 Years and Above Benzinga

Dec 14, 2021

04:47PM EST FDA Announces Revisions To Janssen COVID-19 Fact Sheet; Now Includes Contraindication To Janssen Administration To People With History Of Thrombosis With TTS After Vaccine Benzinga

03:33PM EST Cornell Imposes Lockdown After Omicron Is Detected On Campus Benzinga

11:27AM EST World Health Organization Chief Tedros Says People Are Wrong To Consider Omicron Variant As Causing Mild Disease, That Sentiment Could Overwhelm Unprepared Health Systems Benzinga

10:16AM EST NFL Mandates Booster Shots Among Team Staff Benzinga

Dec 13, 2021

05:24PM EST J&J Talcum Powder Woes Continue As SC Declines To Hear The RTTNews

12:12PM EST Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients Benzinga

11:44AM EST How Pfizer Is Getting Into Cannabis With $6.7B Arena Pharma Deal Benzinga

11:24AM EST UK Reports First Omicron Death, PM Johnson Encourages Boosters Benzinga

09:52AM EST Janssen Secures Conditional EU Marketing Authorization For Rybrevant in Lung Cancer Setting Benzinga

09:48AM EST JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma Benzinga

06:04AM EST Genmab Announced Janssen has Received Conditional European Marketing Authorization for RYBREVANT(amivantamab) for Patients with Advanced Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations, after Failure of Platinum-base Benzinga

Dec 11, 2021

12:19PM EST Janssen Presented Updated Results Evaluating First-in-Class Talquetamab (GPRC5DxCD3 Bispecific Antibody) in Heavily Pretreated Patients with Multiple Myeloma at ASH 2021; Said No New Safety Signals Were Identified With Longer Follow-up of Either Dose Cohort Benzinga

Dec 10, 2021

01:40PM EST Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results PR Newswire

11:43AM EST UK Health Security Agency Says Booster Increases Protection Against Mild COVID Disease To Around 70%-75% In Real World Study Looking At 581 People With Confirmed Omicron Variant Benzinga

08:41AM EST 'House Democrats find in three-year investigation that drug prices are 'unsustainable, unjustifiable and unfair'' -Washington Post Benzinga

Dec 9, 2021

09:59PM EST WHO Strategic Advisory Group Of Experts Interim Recommendation Supports Use Of Johnson & Johnson COVID-19 Vaccine As Booster Benzinga

09:56PM EST 'Gov. Kathy Hochul said she will announce new policies tomorrow as more cases of the Omicron variant are confirmed in New York.' -CBS New York Benzinga

09:51PM EST JNJ Says Working On mRNA Technologies Benzinga

09:42PM EST 'Senate votes to repeal key Biden administration vaccine and testing policy' -Earlier Washington Post Report Benzinga

05:01PM EST Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster PR Newswire

06:32AM EST J&J : Michael Sneed, EVP, Global Corporate Affairs And Chief Communication Officer, To Retire On April 1, 2022 RTTNews

06:31AM EST Johnson & Johnson Appoints Senior Leaders to Executive Committee PR Newswire

Dec 7, 2021

12:44PM EST Johnson & Johnson Posts Additional RSV Vaccine Data Benzinga

06:34AM EST Janssen Announces Respiratory Syncytial Virus Adult Vaccine Candidate Maintains High Efficacy Regardless of Lower Respiratory Tract Disease Severity Benzinga

Dec 6, 2021

01:50PM EST CNN Reporter Tweets 'Good news on Omicron and vaccines: "The early indication is that you are going to be protected against serious illness with two doses of mRNA-containing vaccines. And the booster dose can increase antibodies,"' Benzinga

10:27AM EST UPDATE: Children Aged 5-11 Required To have At Least 1 COVID Vaccine Shot For Indoor Activities Starting Dec. 14 Benzinga

08:09AM EST Johnson & Johnson Booster COVID-19 Shot Shows Encouraging Action After Pfizer/BioNTech Jab Benzinga

Dec 5, 2021

08:43PM EST Johnson & Johnson (JNJ) said preliminary results from an independent study showed that a booster shot of its COVID-19 vaccine (Ad26.COV2.S), administered at six months after a two-dose primary regimen of BNT162b2, increased both antibody and T-cell responses. The results showed the potential benefits of heterologous boosting (mix-and-match). RTTNews

06:08PM EST Johnson & Johnson Announced its COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses Benzinga

05:04PM EST Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses PR Newswire

09:15AM EST CDC Director Walensky Said Omicron Covid-19 Cases Found in at Least 15 U.S. States; Said Delta Variant of Covid-19 Still Makes Up Majority of U.S. Cases Benzinga

Dec 3, 2021

07:25PM EST Janssen to Showcase Progress on Respiratory Syncytial Virus (RSV) Vaccine PR Newswire

03:40PM EST Pfizer, BioNTech Shares Quiet Following Comment From Biden Chief Medical Advisor Dr. Fauci Says Pfizer's COVID-19 Vaccine Likely To Retain Effect Against Omicron Strain Benzinga

07:40AM EST The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering Benzinga

Dec 2, 2021

04:17PM EST NYC Sets Vaccine Mandate For Religious, Private School Staff Benzinga

01:53PM EST President Biden Says Team Is Working With Vaccine Firms For Contingency Plan For Vaccines, Boosters Benzinga

06:52AM EST Janssen's Subcutaneous Darzalex Combo Wins FDA Approval For Pretreated Multiple Myeloma Benzinga

Dec 1, 2021

10:36PM EST Amgen : FDA Approves Kyprolis Combination Regimen For RTTNews

12:03PM EST Former German PM Merkel Proposes Mandatory COVID Shots Starting Feb. 2022 Benzinga

11:57AM EST J&J Shares At New Session High, Up 2.2%; FDA Has Approved Co., Amgen's Dexamethasone For Multiple Myeloma; Amgen Shares Quiet Benzinga

08:34AM EST Zymeworks Reports Its Second J&J's Janssen Bispecific Antibody To Begin Clinical Development Utilizing Azymetric, EFFECT Therapeutic Platforms Benzinga

07:18AM EST WHO Official Says Some of the Early Indications Is That Most Omicron Cases Are Mild, No Severe Cases Benzinga

05:45AM EST Norway Detected First Two Cases of Omicron Covid Variant Benzinga

05:11AM EST Japan Confirmed Second Case of Omicron Variant of the Covid-19 on Wednesday Benzinga

05:00AM EST Israel's Health Minister Nitzan Horowitz Said Individuals Fully Vaccinated Against Corona Within Six Months or With the Booster are Protected Against the Omicron Variant Benzinga

Nov 30, 2021

04:51PM EST What Does Johnson & Johnson's Debt Look Like? Benzinga

04:49PM EST Johnson & Johnson Vice Chairman Says Actively Investigating If There Is Any Inherent Issue With The Vaccine On Omicron Variant Benzinga

04:48PM EST WHO Africa Director Says The Aspen, J&J Deal Is Very Important To Boost Africa's Ability To Produce Its Own COVID And Other Vaccines Benzinga

04:48PM EST Johnson & Johnson Discussions To License COVID-19 Vaccine To Aspen Pharmacare Reach Advanced Stage. BZ NOTE: Aspen Pharmacare Intends To Distribute Vaccines In Africa Benzinga

04:48PM EST Oxford University Says No Evidence Omicron Variant Defeats Vaccine Benzinga

04:42PM EST Two Israeli Doctors Infected with Omicron Variant Benzinga

04:40PM EST China Xinhua News Says No Omicron Cases Reported on Chinese Mainland So Far Benzinga

04:39PM EST Dutch Authorities Said Omicron Variant Was Detected in the Netherlands on Nov. 19, Before S. Africa Flights Benzinga

04:39PM EST U.S. Equity Futures, European Markets Fall Following Moderna CEO Comments on Vaccines Likely Less Effectiveness Against Omicron Variant Benzinga

04:39PM EST Moderna CEO Said in Financial Times Interview Vaccines are Likely Less Effective against Omicron; Said Mutations Mean Existing Vaccines Likely Need Modifying Benzinga

04:17PM EST White House Says Nothing Has Changed In Our Deadline For Required Vaccinations Of Federal Workers Benzinga

04:09PM EST Johnson & Johnson Shares Move Higher; Credit Suisse Sets $200 Price Target, Reiterates Outperform Benzinga

Nov 29, 2021

09:06PM EST The U.S. Centers for Disease Control and Prevention has strengthened its recommendation for COVID-19 booster shots for all U.S. adults amid growing concern about the new omicron variant. The agency previously said all adults may get the booster shot. RTTNews

08:36AM EST Major covid vaccine makers said they are investigating Omicron, the new, heavily mutated coronavirus variant that was first detected in South Africa, and working to adapt their vaccines, if needed. RTTNews

08:05AM EST Johnson & Johnson To Evaluate Its COVID-19 Vaccine Against Omicron Variant Benzinga

06:26AM EST World Health Organization Tweeted Earlier "We don't yet know whether Omicron is associated with more: -transmission -severe #COVID19 disease -risk of reinfections -risk of evading vaccines. Scientists at WHO & around the Benzinga

05:58AM EST Italy's Radiocor Says Italy Reported Four Omicron Variant Cases Benzinga

Nov 28, 2021

05:07PM EST NIH Director Collins Said Current Vaccinations Likely to Protect Against Omicron Benzinga

09:14AM EST National Institute of Allergy and Infectious Diseases Director Fauci Tells ABC News Too Early to Say if We Need New Lockdowns or Mandates Benzinga

Nov 27, 2021

09:23AM EST Two cases of Omicron Variant Detected in UK: Individuals in Chelmsford and Nottingham had Traveled to Southern Africa Benzinga

Nov 26, 2021

12:18PM EST Johnson & Johnson Says Has Already Begun Testing Its Vaccine's Effectiveness Against New Variant Benzinga

05:43AM EST France, Czech Republic, Singapore Among Countries Reported to Restrict Travel from Southern Africa Due to "Nu" Variant Benzinga

05:15AM EST Total of 84 Confirmed Cases of COVID-19 Variant B.1.1.529 With 77 in S. Africa, 4 in Botswana, 2 in Hong Kong, 1 in Israel Benzinga

05:12AM EST U.S. Equity Futures Sharply Lower; Covid-Related Stocks Surge on Reports of New, Heavily-Mutated Strain, Feared to be More Infectious than Delta Variant Benzinga

05:09AM EST Israeli, Who Returned from Malawi, Tested Positive for New Highly-Mutated Covid-19 Strain Reported in S. Africa Benzinga

Nov 24, 2021

02:00PM EST Johnson & Johnson's COVID-19 Shot Wins Its First Full Approval In Canada Benzinga

08:38AM EST Janssen, the pharmaceutical companies of Johnson & Johnson (JNJ), announced that Health Canada has approved its single-shot COVID-19 vaccine to prevent COVID-19 in individuals 18 years of age and older. RTTNews

08:18AM EST Health Canada Approves JNJ's COVID-19 Vaccine To Prevent Individuals 18 Years And Older RTTNews

06:44AM EST World Health Organization Issues Interim Statement on Covid-19 Vaccination for Children and Adolescents, Says They Have Lower Risk of Severe Disease Benzinga

06:04AM EST South Africa Asked Johnson & Johnson and Pfizer to Delay Delivery of COVID-19 Vaccines Due to Oversupply Benzinga

Nov 23, 2021

05:08PM EST Fauci Says Cast Majority Of Vaccinated Americans Should Get COVID-19 Boosters; Says Has Seen No Safety Signal Related To COVID-19 Vaccine Campaign For Children Benzinga

02:16PM EST Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst Benzinga

02:09PM EST Johnson & Johnson Option Alert: Jun 17 $175 Calls at the Ask: 171 @ $3.15 vs 4150 OI; Ref=$160.385 Benzinga

08:21AM EST The European Commission has approved BYANNLI, a 6-monthly paliperidone palmitate, developed by The Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ), for the maintenance treatment of schizophrenia in adults who are clinically stable on *1-monthly paliperidone palmitate (PP1M) or *3-monthly paliperidone palmitate (PP3M). RTTNews

07:17AM EST Novartis May Have Buyer(s) For Its Sandoz Unit - Report Benzinga

07:01AM EST JNJ: European Commission Approves BYANNLI For Maintenance Treatment Of Schizophrenia In Adults RTTNews

Nov 22, 2021

12:41PM EST EU Says Decision On J&J COVID-19 Booster Shot Expected 'Within Weeks' Benzinga

12:12PM EST Check Out What Whales Are Doing With JNJ Benzinga

08:05AM EST EMA Evaluating Application For Use Of A Booster Dose Of COVID-19 Vaccine Janssen To Be Given At Least Two Months After First Dose To People; Outcome Expected Within Weeks, Unless Supplementary Information Is Needed, And Will Be Communicated By EMA Benzinga

Nov 18, 2021

10:53AM EST J&J Is Confident It Will Deliver A Billion COVID-19 Vaccine Doses Next Year, Says Will Give Financial Guidance On Vaccine In Jan. 2022 Benzinga

Nov 15, 2021

02:30PM EST McKesson, Cardinal Health, AmerisourceBergen Face $95B Opioid Trial In Washington: Reuters Benzinga

11:51AM EST Johnson & Johnson Announces Late-Breaking Phase 2 Data For Investigational Oral Factor Xia Inhibitor Milvexian Suggest Favorable Antithrombotic Profile Across Wide Range Of Doses Benzinga

10:37AM EST The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More Benzinga

Nov 12, 2021

07:47AM EST The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares Benzinga

07:25AM EST Healthcare major Johnson & Johnson (JNJ) on Friday said it plans to separate its Consumer Health business, to create a new public company. The planned organizational design for the New Consumer Health Company is expected to be complete by the end of 2022. RTTNews

06:32AM EST J&J Press Release Confirms Separation Of Consumer Health Unit Benzinga

06:32AM EST Johnson & Johnson Plans To Separate Its Consumer Health Business RTTNews

06:31AM EST Consumers, and Unlock Value through Intent to Separate Consumer Health Business PR Newswire

06:21AM EST J&J Will Split Off Its Consumer Unit In Tax-Free Transaction Over Next 18-24 Months Benzinga

Nov 11, 2021

02:27PM EST EU Lists Spinal Cord Inflammation Probable Side Effect Of JNJ's COVID-19 Shot: Reuters Benzinga

Nov 10, 2021

05:15PM EST Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer PR Newswire

12:34PM EST Oklahoma Supreme Court Overturns Opioid Ruling Against Johnson & Johnson Benzinga

Nov 9, 2021

06:29PM EST Apple Names J&J Chair, CEO Alex Gorsky To Co.'s Board Benzinga

04:31PM EST Johnson & Johnson Endows Research!America Outstanding Achievement in Public PR Newswire

11:42AM EST The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data Benzinga

11:08AM EST Alkermes Announces Receipt Of Notices Of Partial Termination From Janssen Pharmaceutica In Respect Of Two License Agreements; Says 'The terminations impact know-how royalties related to sales of long-acting paliperidone products' Benzinga

Nov 5, 2021

03:51PM EDT FDA Authorized Use Under Emergency Use Authorization For J&J's Janssen's COVID-19 Vaccine, 2 Added Batches Of Vaccine Drug Substance Manufactured At Emergent Facility Benzinga

09:44AM EDT '"The end of the pandemic at least as it relates to the United States is in sight right now," says @ScottGottliebMD. "The bottom line is we have an overwhelming toolbox right now to combat COVID."' -Tweet From CNBC's 'Squawk Box' Benzinga

09:15AM EDT US Department of Labor Earlier Issued Emergency Temporary Standard To Protect Workers From Coronavirus: Requires Firms With 100+ Employees To Implement, Enforce Mandatory COVID-19 Vaccine Policy Benzinga

Nov 4, 2021

01:27PM EDT This Are The 5 Largest European Stocks Benzinga

Nov 2, 2021

10:54AM EDT The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US Benzinga

10:50AM EDT Johnson & Johnson, Costco Settle Lawsuits Over Recalled Sunscreen Products: Reuters Benzinga

Nov 1, 2021

09:31AM EDT J&J Says Janssen Phase 3 Data Show First-In-Class Tremfya Provided Durable Improvements In Measures Of Psoriatic Arthritis Disease Activity Through 2 Years Benzinga

Oct 30, 2021

02:24PM EDT J&J Settles Anti-psychotic Drug Risperdal Lawsuits With $800 Million In Expenses Benzinga

Oct 29, 2021

01:03PM EDT COVID Vaccines Protect Better Than Earlier Infection, CDC Says Benzinga

Oct 28, 2021

03:56PM EDT FDA Restricts Sale, Approves New Labeling Of Breast Implants Benzinga

02:50PM EDT White House Says Decisions On Vaccine Intellectual Property Waivers Will Not occur At G20 But At Coming Trade Meeting Benzinga

12:20PM EDT Millions Of JNJ COVID-19 Shots Sit Idle At Emergent's Baltimore Plant: Reuters Benzinga

08:26AM EDT The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug Benzinga

06:24AM EDT Reuters Reported 30M to 50M Doses of Johnson & Johnson's Covid-19 Vaccine Stored in Emergent Biosolutions' Plant in Baltimore Awaiting Green Light from U.S. Regulators to Ship Benzinga

Oct 27, 2021

12:21PM EDT Looking At Johnson & Johnson's Recent Whale Trades Benzinga

Oct 26, 2021

01:55PM EDT Johnson & Johnson Settles Opioid Claims In Texas For $291.8M Benzinga

12:30PM EDT Johnson & Johnson Says Co Removed From Pending Texas State, Subdivision Litigation, Including 2 Bellwether Trials Scheduled For Early 2022 Benzinga

12:00PM EDT Watching J&J Shares As Hearing Texas Attorney General Said Reached Settlement With Co. Related To Statewide Opioid Case Benzinga

07:25AM EDT Protagonist Therapeutics Earns $7.5M Milestone Payment From IL-23 Receptor Collaboration With Janssen Benzinga

07:19AM EDT Protagonist Earns $7.5 Mln Milestone Payment From IL-23 Receptor Collaboration With Janssen RTTNews

Oct 25, 2021

09:35AM EDT J&J's Janssen Reports Data From 2 Analyses Of Stelara For Treatment Of Adults With Moderately To Severely Active Crohn's Disease, Ulcerative Colitis Benzinga

Oct 24, 2021

11:45AM EDT The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More Benzinga

Oct 22, 2021

04:26PM EDT A-List Executive Team, Big-Name Backers Fail to Lift Abbisko IPO Benzinga

03:30PM EDT Q3 Earnings Report Recap; TSLA, NFLX, JNJ, PG Benzinga

10:14AM EDT Johnson & Johnson's Shot Success Overshadowed by Baby Powder Cancer Suit Benzinga

10:02AM EDT Walgreens said Friday that eligible individuals can now receive Moderna and Johnson & Johnson COVID-19 vaccine booster shots in stores nationwide following the Food and Drug Administration Emergency Use Authorization and new guidance from the Centers for Disease Control and Prevention (CDC). RTTNews

09:30AM EDT Walgreens Now Offering Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots Nationwide Benzinga

07:36AM EDT The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs Benzinga

Oct 21, 2021

09:18PM EDT Johnson & Johnson (JNJ) said Thursday that the U.S. Centers for Disease Control and Prevention or CDC Advisory Committee on Immunization Practices or ACIP, has recommended its COVID-19 vaccine as a booster for all eligible individuals who receive an authorized COVID-19 vaccine. RTTNews

09:03PM EDT CDC Panel Recommends J&J COVID-19 Vaccine As Booster For All Eligible Individuals Who Receive COVID-19 Vaccines RTTNews

07:49PM EDT Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines PR Newswire

05:17PM EDT U.S. CDC Advisers Vote To Recommend Moderna COVID-19 Vaccine Booster For Older Adults, Some High-Risk Individuals; CDC Votes To Recommend Booster Shot For Those Who Received Johnson & Johnson Vaccine Benzinga

04:00PM EDT Johnson & Johnson (JNJ) Declares $ 1.06 Dividend for Q4 21, Record Date 11/23/2021 RTTNews

03:22PM EDT Johnson & Johnson Declares Quarterly Dividend Of $1.06/share, Payable Dec. 7/ Record Nov. 23 RTTNews

02:49PM EDT Vaccine Stocks Move Lower; White House Says We Need Every World Trade Organization Member To Step Up And Support A Vaccine Intellectual Property Waiver Benzinga

02:39PM EDT Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021 PR Newswire

12:12PM EDT Which Vaccine Stock Will Benefit Most From FDA's "Mix And Match" Approval? Benzinga

document.getElementById("rvjJqX").onerror = function(){this.style.display='none';}; .dark-mode .zC0ksV{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .zC0ksV{ color: #333333; background-color: white; border: 2px solid #333333; }JNJJohnson & Johnsonstock NYSE

JNJ
Johnson & Johnson
stock NYSE